Comprehensive molecular profiling of lung adenocarcinoma.
about
FGFR3-TACC3 fusion in solid tumors: mini reviewTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsThe value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancersUnderstanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?Practical aspects of NGS-based pathways analysis for personalized cancer science and medicineIs the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?Gene aberrations for precision medicine against lung adenocarcinomaImmunotherapy for lung cancerMicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for TreatmentThe dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutationsMolecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugsLung cancer biomarkers, targeted therapies and clinical assaysMEK and PI3K inhibition in solid tumors: rationale and evidence to dateThe mutational landscape of hepatocellular carcinomaATM rs189037 (G > A) polymorphism and risk of lung cancer and head and neck cancer: A meta-analysisThe distinctive nature of adenocarcinoma of the lungNext-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future DirectionsIdentifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancerPatterns of Chromosomal Aberrations in Solid TumorsCurrent and future molecular profiling of cancer by next-generation sequencingA decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectivesReverse phase protein arrays in signaling pathways: a data integration perspectiveDysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistanceMediator kinase module and human tumorigenesisNew and emerging factors in tumorigenesis: an overviewFibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implicationsPredictive biomarkers in precision medicine and drug development against lung cancerBeyond ALK-RET, ROS1 and other oncogene fusions in lung cancerThe minority report: targeting the rare oncogenes in NSCLCTargeting cancer with kinase inhibitorsHarnessing immunosurveillance: current developments and future directions in cancer immunotherapyConcepts in solid tumor evolutionCo-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumorsResponse to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skippingDifferent prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer.Analyzing and interpreting genome data at the network level with ConsensusPathDBCRISPR-Cas9: from Genome Editing to Cancer ResearchThe Impact of Genomic Profiling for Novel Cancer Therapy--Recent Progress in Non-Small Cell Lung Cancer
P2860
Q26740578-F2751DA2-09C2-47ED-BFE0-DD1FB08E03E6Q26741318-B4E6A95D-D41C-4FDE-B6E1-902877C00ED6Q26747403-CBBEDC27-7377-4AAA-B671-FB5886C335BFQ26748581-60BF9001-0F13-4214-BD1F-50CD9E03B449Q26748603-42D53353-7CFA-4218-A922-D0B8E6EF5E19Q26748741-0B74D0C2-BCFA-46E5-B661-5672158C641EQ26749348-2704B2E5-1FC4-42F2-9410-6CE7258B4389Q26751254-7D4A0693-BAD8-46A8-98EE-756BF74670FDQ26752548-B693676E-2ED4-46F7-845D-5296084DAE83Q26753387-53DA6ED1-87E1-408F-9C1B-DD7D7739347FQ26769659-96AC33A4-1CD2-4C37-98FB-05BB041E8746Q26775396-7D5B7A62-EAA2-4A61-A2F9-3067AC2F463FQ26775573-E7A24664-6BF1-4A7A-82C9-A87D6CC99A21Q26777478-2458E643-4EA9-4F23-8C42-D37CEE41B82CQ26778613-724B7A87-A69D-4468-AE37-FE6CC6A67296Q26781159-565FC714-EF32-43B9-856C-C99155B455C6Q26781271-FA887215-C7F1-4787-8B5B-BA49A12AA505Q26781333-C3E9C0E1-0862-4DB9-8152-6CEDD7A14C96Q26781810-AE868E05-555A-4819-BF7F-07F62C0593A0Q26786127-4DC7DBC4-2A3E-47C4-8CB7-E042F391E48AQ26796272-AF496AF6-5985-4E87-A66B-66081E948F55Q26797297-66C5FD1F-E740-40DA-B9ED-E92B484B4EA1Q26799716-D3CBA222-D0A3-4AB7-B61A-411B4AD7863FQ26799900-EEEAC737-2462-4DCE-8F25-7BA3A21200C0Q26800203-91DB80E1-5FC5-4468-8633-9E6610251C70Q26801253-331EC521-7DE5-4E7D-84CC-4F7D67E4AFF4Q26801718-26A1187E-A118-400C-9BEC-C85EF3BF9BDEQ26824536-7C3F245B-5A17-4CC7-B6D3-1962074A811BQ26851421-5933B59B-D008-4D24-B174-77887BD3BDE7Q26851636-B761947B-1C02-4FD0-B5EF-E85C283C3B0DQ26865765-2CB1C1EB-0BD5-4F07-B99B-D231A01E7038Q27021570-F43577D9-2836-49B8-9995-0A158F1F2ED8Q27024092-B4DA9524-751A-4C82-9EB4-0452AA08C3B2Q27345462-3E4C4718-6E45-4D90-827B-952E9D12D567Q27853154-4F457E1C-5F7F-4367-BF99-DF8192884A82Q27853167-0D1C03A9-737D-4449-BEDC-B7E51BB2584CQ27853286-A9A7E461-2FB1-4790-9E24-2D4EB38CB5DAQ27887656-10EC5AB1-2D0D-4047-8A9B-5C43F99CAC54Q28066263-42FCC240-A742-4BE6-A287-C43744D42D30Q28067196-DAD29DB5-B1BD-488D-B11A-651D9B06E341
P2860
Comprehensive molecular profiling of lung adenocarcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comprehensive molecular profiling of lung adenocarcinoma
@nl
Comprehensive molecular profiling of lung adenocarcinoma.
@ast
Comprehensive molecular profiling of lung adenocarcinoma.
@en
type
label
Comprehensive molecular profiling of lung adenocarcinoma
@nl
Comprehensive molecular profiling of lung adenocarcinoma.
@ast
Comprehensive molecular profiling of lung adenocarcinoma.
@en
prefLabel
Comprehensive molecular profiling of lung adenocarcinoma
@nl
Comprehensive molecular profiling of lung adenocarcinoma.
@ast
Comprehensive molecular profiling of lung adenocarcinoma.
@en
P2860
P3181
P356
P1433
P1476
Comprehensive molecular profiling of lung adenocarcinoma.
@en
P2093
Cancer Genome Atlas Research Network
P2860
P2888
P304
P3181
P356
10.1038/NATURE13385
P407
P577
2014-07-09T00:00:00Z
P5875
P6179
1038580641